BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 31796767)

  • 1. Clinical safety of ProMRI implantable cardioverter-defibrillator systems during head and lower lumbar magnetic resonance imaging at 1.5 Tesla.
    Bauer WR; Lau DH; Wollmann C; McGavigan A; Mansourati J; Reiter T; Frömer S; Ladd ME; Quick HH
    Sci Rep; 2019 Dec; 9(1):18243. PubMed ID: 31796767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical safety of the ProMRI implantable cardioverter-defibrillator systems during head and lower lumbar magnetic resonance imaging at 3 T: results of the ProMRI 3T ENHANCED Master study.
    Zbinden R; Wollmann C; Brachmann J; Michaelsen J; Steinwender C; Kovoor P; Kelle S; McGavigan AD; Ching CK; Figtree GA; Schmidt J; Timmel T; Lotz J
    Europace; 2019 Nov; 21(11):1678-1685. PubMed ID: 31322701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical safety of the ProMRI pacemaker system in patients subjected to head and lower lumbar 1.5-T magnetic resonance imaging scanning conditions.
    Bailey WM; Rosenthal L; Fananapazir L; Gleva M; Mazur A; Rinaldi CA; Kypta A; Merkely B; Woodard PK;
    Heart Rhythm; 2015 Jun; 12(6):1183-91. PubMed ID: 25680307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical safety of an MRI conditional implantable cardioverter defibrillator system: A prospective Monocenter ICD-Magnetic resonance Imaging feasibility study (MIMI).
    Kypta A; Blessberger H; Hoenig S; Saleh K; Lambert T; Kammler J; Fellner F; Lichtenauer M; Steinwender C
    J Magn Reson Imaging; 2016 Mar; 43(3):574-84. PubMed ID: 26335332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical safety of the Iforia implantable cardioverter-defibrillator system in patients subjected to thoracic spine and cardiac 1.5-T magnetic resonance imaging scanning conditions.
    Awad K; Griffin J; Crawford TC; Lane Cox S; Ferrick K; Mazur A; Pena RE; Lloyd SG; Michalski J; Johnson W; Bailey WM
    Heart Rhythm; 2015 Oct; 12(10):2155-61. PubMed ID: 26049048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical safety of the ProMRI pacemaker system in patients subjected to thoracic spine and cardiac 1.5-T magnetic resonance imaging scanning conditions.
    Bailey WM; Mazur A; McCotter C; Woodard PK; Rosenthal L; Johnson W; Mela T;
    Heart Rhythm; 2016 Feb; 13(2):464-71. PubMed ID: 26409098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficiency of low-field magnetic resonance imaging in patients with cardiac rhythm management devices.
    Schukro C; Puchner SB
    Eur J Radiol; 2019 Sep; 118():96-100. PubMed ID: 31439265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3 Tesla magnetic resonance imaging in patients with cardiac implantable electronic devices: a single centre experience.
    Fluschnik N; Tahir E; Erley J; Müllerleile K; Metzner A; Wenzel JP; Guerreiro H; Adam G; Blankenberg S; Kirchhof P; Tönnis T; Nikorowitsch J
    Europace; 2023 Feb; 25(2):571-577. PubMed ID: 36413601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing access to MRI of patients with magnetic resonance-conditional pacemaker and implantable cardioverter defibrillator systems: the Really ProMRI study design.
    Maglia G; Curnis A; Brieda M; Anaclerio M; Caccavo V; Bonfanti P; Melissano D; Caravati F; Giovene L; Gargaro A;
    J Cardiovasc Med (Hagerstown); 2015 Oct; 16(10):715-20. PubMed ID: 25252037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MRI Safety for Patients Implanted With the MRI Ready ICD System: MRI Ready Study Results.
    Nazarian S; Cantillon DJ; Woodard PK; Mela T; Cline AM; Strickberger AS;
    JACC Clin Electrophysiol; 2019 Aug; 5(8):935-943. PubMed ID: 31439295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Safety of Cardiac and Thoracic Magnetic Resonance Imaging in Patients with Cardiac Implantable Electronic Devices.
    Dandamudi S; Collins JD; Carr JC; Mongkolwat P; Rahsepar AA; Tomson TT; Verma N; Arora R; Chicos AB; Kim SS; Lin AC; Passman RS; Knight BP
    Acad Radiol; 2016 Dec; 23(12):1498-1505. PubMed ID: 27717762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Full-Body MRI in Patients With an Implantable Cardioverter-Defibrillator: Primary Results of a Randomized Study.
    Gold MR; Sommer T; Schwitter J; Al Fagih A; Albert T; Merkely B; Peterson M; Ciuffo A; Lee S; Landborg L; Cerkvenik J; Kanal E;
    J Am Coll Cardiol; 2015 Jun; 65(24):2581-2588. PubMed ID: 25982014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety of Magnetic Resonance Imaging in Patients with Cardiac Devices.
    Nazarian S; Hansford R; Rahsepar AA; Weltin V; McVeigh D; Gucuk Ipek E; Kwan A; Berger RD; Calkins H; Lardo AC; Kraut MA; Kamel IR; Zimmerman SL; Halperin HR
    N Engl J Med; 2017 Dec; 377(26):2555-2564. PubMed ID: 29281579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnetic resonance imaging in patients with a subcutaneous implantable cardioverter-defibrillator.
    Keller J; Neužil P; Vymazal J; Janotka M; Brada J; Žáček R; Vopálka R; Weichet J; Reddy VY
    Europace; 2015 May; 17(5):761-6. PubMed ID: 25687749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experiences of magnetic resonance imaging scanning in patients with pacemakers or implantable cardioverter-defibrillators.
    Han D; Kang SH; Cho Y; Oh IY
    Korean J Intern Med; 2019 Jan; 34(1):99-107. PubMed ID: 29609452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Safety of cardiac pacemakers and implantable cardioverter-defibrillators in magnetic resonance imaging. Assessment of the aggregate function at 1.5 tesla].
    Nordbeck P; Bauer WR
    Dtsch Med Wochenschr; 2008 Mar; 133(13):624-8. PubMed ID: 18351504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implications of pacemakers and implantable cardioverter defibrillators in urological practice.
    Ubee SS; Kasi VS; Bello D; Manikandan R
    J Urol; 2011 Oct; 186(4):1198-205. PubMed ID: 21849189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical utility and safety of a protocol for noncardiac and cardiac magnetic resonance imaging of patients with permanent pacemakers and implantable-cardioverter defibrillators at 1.5 tesla.
    Nazarian S; Roguin A; Zviman MM; Lardo AC; Dickfeld TL; Calkins H; Weiss RG; Berger RD; Bluemke DA; Halperin HR
    Circulation; 2006 Sep; 114(12):1277-84. PubMed ID: 16966586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic Value of MRI in Patients With Implanted Pacemakers and Implantable Cardioverter-Defibrillators Across a Cross Population: Does the Benefit Justify the Risk? A Proof of Concept Study.
    Samar H; Yamrozik JA; Williams RB; Doyle M; Shah M; Bonnet CA; Biederman RWW
    JACC Clin Electrophysiol; 2017 Sep; 3(9):991-1002. PubMed ID: 29759724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical safety and performance of a MRI conditional pacing system in patients undergoing cardiac MRI.
    Ching CK; Chakraborty RN; Kler TS; Pumprueg S; Ngarmukos T; Chan JYS; Anand S; Yadav R; Sitthisook S; Yim KW; Jaswal RK; Bhargava K
    Pacing Clin Electrophysiol; 2017 Dec; 40(12):1389-1395. PubMed ID: 29090491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.